CU Boulder researchers have developed a treatment that uses high-frequency ultrasound waves paired with sound-responsive particles to soften cancer tumors by reducing their protein content. By altering the tumor structure without harming healthy tissue, this approach may enhance the effectiveness of chemotherapy while offering a safer treatment option.

Intestinal ultrasound is a preferred monitoring method for inflammatory bowel disease among US patients, compared with colonoscopy, according to a study published in Digestive Diseases and Sciences. A survey found 60.7% of patients who have had an IUS said it was "definitely" preferred, compared with 22.4% for colonoscopy. Emily Gore, Icahn School of Medicine at Mount Sinai and colleagues said IUS "is highly acceptable, well tolerated, and preferred by our US population."

A study in the Annals of Internal Medicine indicates GLP-1 drugs such as Ozempic and Zepbound likely have minimal impact on a person's risk for obesity-related cancers. The study, which analyzed 48 trials involving 94,245 participants, found that the drugs had little to no effect on risk for cancers such as breast, thyroid, pancreatic and kidney. The study's limitations include its short follow-up period and the fact that none of the trials was designed to measure cancer outcomes.

An analysis of data from more than 2.6 million women, published in the Journal of the American Heart Association, associated uterine fibroids with an 81% higher risk of heart disease over 10 years. Women younger than age 40 had the highest risk. Researchers said from 20% to 80% of women could develop fibroids by age 50.

A new American Hospital Association report based on data from Vizient shows that survival rates in US hospitals have increased 30% since 2019, central line-associated bloodstream infections have decreased 24%, and urinary tract infections linked to catheters decreased 25%, as of mid-2025. Breast and colon cancer screenings increased 95% over the study period, according to the report.